Michael Spigarelli MD PhD MBA

Michael Spigarelli MD PhD MBA has extensive work experience in the medical and scientific fields. Currently, they serve as the Chief Medical Officer and Chief Scientific Officer at PsyBio Therapeutics Corp, where they lead various departments including medical affairs, clinical operations, research and development, regulatory and quality affairs, manufacturing, and program management. Their role involves developing new psychoactive therapies to address mental health issues.

Before joining PsyBio Therapeutics Corp, Dr. Spigarelli worked as a Principal at Research Strategy LLC starting in 2015. Michael Spigarelli also held the position of Chief Medical Officer at Lumen Bioscience from 2020 to 2021.

Dr. Spigarelli's prior experience includes serving as the Vice President of Medical Affairs at Immucor, Inc. from 2016 to 2020. In this role, they had the responsibility of leading medical and clinical issues, customer support and research, product design and development, clinical risk assessment, and regulatory compliance.

Michael Spigarelli has also worked as a Professor in Pediatrics, Internal Medicine, and Pharmaceutics & Therapeutics at the University of Utah from 2011 to 2015. Prior to that, they held the position of Associate Professor at both the University of Cincinnati and Cincinnati Children's Hospital Medical Center.

Dr. Spigarelli's diverse background and leadership roles demonstrate their expertise in medical affairs, clinical operations, research and development, regulatory compliance, and program management.

Michael Spigarelli MD PhD MBA completed their education in a sequential manner, starting with a Bachelor of Science (BS) degree in Chemistry and Cellular Molecular Biology from the University of Michigan College of Literature, Science, and the Arts from 1984 to 1988. Michael Spigarelli then pursued a Doctor of Medicine (MD) degree from the University of Michigan Medical School, completing it in the same time frame as their PhD in Medicinal Chemistry from the University of Michigan - Rackham Graduate School, between 1988 and 1996. After obtaining their MD and PhD, they pursued further education and received a Master of Business Administration (MBA) degree in Business Administration, Management and Operations from the University of Utah - David Eccles School of Business from 2013 to 2015.

In addition to their extensive education, Michael Spigarelli MD PhD MBA has obtained several certifications. Michael Spigarelli is board certified in Adolescent Medicine by the American Board of Internal Medicine, board certified in Clinical Pharmacology by the American Board of Clinical Pharmacology, and board certified in Internal Medicine by the American Board of Internal Medicine. Michael Spigarelli is also board eligible in Pediatrics according to the American Board of Pediatrics. The specific months and years of obtaining these certifications are not provided.